GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » Equity-to-Asset

Nuvation Bio (Nuvation Bio) Equity-to-Asset : 0.96 (As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Nuvation Bio's Total Stockholders Equity for the quarter that ended in Sep. 2021 was $769.37 Mil. Nuvation Bio's Total Assets for the quarter that ended in Sep. 2021 was $797.79 Mil.

The historical rank and industry rank for Nuvation Bio's Equity-to-Asset or its related term are showing as below:

NUVB' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.14   Med: 0.97   Max: 0.99
Current: 0.96

During the past 2 years, the highest Equity to Asset Ratio of Nuvation Bio was 0.99. The lowest was 0.14. And the median was 0.97.

NUVB's Equity-to-Asset is not ranked
in the Biotechnology industry.
Industry Median: 0.67 vs NUVB: 0.96

Nuvation Bio Equity-to-Asset Historical Data

The historical data trend for Nuvation Bio's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Equity-to-Asset Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
Equity-to-Asset
0.82 0.96

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Equity-to-Asset Get a 7-Day Free Trial 0.82 0.97 0.97 0.96 0.96

Competitive Comparison of Nuvation Bio's Equity-to-Asset

For the Biotechnology subindustry, Nuvation Bio's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuvation Bio's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Equity-to-Asset falls into.



Nuvation Bio Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Nuvation Bio's Equity to Asset Ratio for the fiscal year that ended in Dec. 2020 is calculated as

Equity to Asset (A: Dec. 2020 )=Total Stockholders Equity/Total Assets
=119.296/145.004
=

Nuvation Bio's Equity to Asset Ratio for the quarter that ended in Sep. 2021 is calculated as

Equity to Asset (Q: Sep. 2021 )=Total Stockholders Equity/Total Assets
=769.366/797.791
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio  (NYSE:NUVB) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Nuvation Bio Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (Nuvation Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.